Buyback of Commercial Papers
BIOCON · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Biocon Ltd fully bought back two Commercial Papers (CPs) worth Rs. 2,000 Crores on January 30, 2026. The buyback includes ISIN INE376G14040 with a face value of Rs. 1,800 Crores (originally issued on December 22, 2025) and ISIN INE376G14057 with a face value of Rs. 200 Crores (originally issued on January 2, 2026). The proceeds from these CPs were used for acquiring equity shares in a subsidiary and for redemption and acquisition of debentures. The company confirmed that all payment obligations have been fulfilled, asset classification of bank facilities remains 'Standard,' and there has been no material adverse change in financial status affecting credit ratings. The buyback was completed in line with FIMMDA guidelines and with the consent of CP holders.
Early retirement of Rs. 2,000 Cr in short-term debt signals strong liquidity and reduces near-term repayment obligations, which is marginally positive for the company's financial flexibility. No negative credit signals — asset classification remains Standard and no adverse rating impact.